Possible Risk Factors for Candida Esophagitis in Immunocompetent Individuals

被引:19
|
作者
Nassar, Yousef [1 ]
Eljabbour, Tony [2 ]
Lee, Hwajeong [2 ]
Batool, Asra [3 ]
机构
[1] Albany Med Ctr, Dept Med, 43 New Scotland Ave, Albany, NY 12208 USA
[2] Albany Med Ctr, Dept Pathol, 43 New Scotland Ave, Albany, NY 12208 USA
[3] Albany Med Ctr, Dept Med, Div Gastroenterol, 43 New Scotland Ave, Albany, NY 12208 USA
关键词
Candida esophagitis; Healthy; Esophageal candidiasis; Proton pump inhibitors;
D O I
10.14740/gr1019w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Candida esophagitis (CE) is a condition typically diagnosed in patients who are immunocompromised. Risk factors leading to the development of CE in immunocompetent patients have not been entirely elucidated. This study set out to identify risk factors associated with the development of CE in immunocompetent patients. Methods: This study was a single-center retrospective chart review. Patients diagnosed with CE confirmed by endoscopic biopsy or brushings at our hospital between 2007 and 2017 were reviewed. The medical histories, endoscopy reports and pathology results were noted. Abdominal pain, heartburn, dysphagia and odynophagia were the common indications for endoscopy. A total of 241 patients were identified as having been diagnosed with CE by endoscopic brushing or biopsy. Of these patients, 161 were excluded due to the presence of immunocompromising and 80 patients were included who had no underlying immunocompromising conditions. Results: Eighty patients with CE satisfied the inclusion criteria. The mean age of patients at the time of diagnosis was 39.8 years old (95% CI: 34.9 - 44.7). The incidences in men and women were similar in this study (49% women and 51% men). Of these patients, 56 (70%) (95% CI: 59-80%; P < 0.005) were taking proton pump inhibitors (PPIs). Fifteen patients (19%) had a previous upper endoscopy with evidence of reflux esophagitis, and they were all treated with PPIs and subsequently found to have CE on repeat upper endoscopy with a mean of 21.6 months of PPI treatment. There were 16 (20%) patients without any attributable risk factor and were completely healthy. Conclusions: CE is an opportunistic infection typically seen in immunocompromised. We report incidence of CE in immunocompetent patients. In our cohort of immunocompetent patients, PPI use was the most common risk factor associated with the development of CE. This could be related to hypochlorhydria resulting from PPI use. However, the cause remains unclear in some patients.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 50 条
  • [1] Prevalence and risk factors for Candida esophagitis among human immunodeficiency virus-negative individuals
    Chen, Yan-Hua
    Jao, Tzu-Ming
    Shiue, Yow-Ling
    Feng, I-Jung
    Hsu, Ping-, I
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (30) : 10896 - 10905
  • [2] Candida esophagitis:Risk factors in non-HIV population in Pakistan
    Javed Yakoob
    Wasim Jafri
    Shahab Abid
    Nadeem Jafri
    Muhammad Islam
    Saeed Hamid
    Hasnain A Shah
    Akbar S Hussainy
    World Journal of Gastroenterology, 2003, 9 (10) : 2328 - 2331
  • [3] Evaluation and management of infectious esophagitis in immunocompromised patients and immunocompetent individuals
    Trukhmanov, A. S.
    Makushina, A. A.
    Storonova, O. A.
    Ivashkina, N. Yu
    TERAPEVTICHESKII ARKHIV, 2020, 92 (08) : 108 - 117
  • [4] Acid Suppression Therapy as a Risk Factor for Candida Esophagitis
    Kim, Kyung-Yup
    Jang, Jae Young
    Kim, Jung-Wook
    Shim, Jae-Jun
    Lee, Chang Kyun
    Dong, Seok Ho
    Kim, Hyo Jong
    Kim, Byung-Ho
    Chang, Young Woon
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (05) : 1282 - 1286
  • [5] Candida esophagitis
    Brncic, N
    Mijandrusic-Sincic, B
    Viskovic, I
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (15-16) : 520 - 520
  • [6] Acid Suppression Therapy as a Risk Factor for Candida Esophagitis
    Kyung-Yup Kim
    Jae Young Jang
    Jung-Wook Kim
    Jae-Jun Shim
    Chang Kyun Lee
    Seok Ho Dong
    Hyo Jong Kim
    Byung-Ho Kim
    Young Woon Chang
    Digestive Diseases and Sciences, 2013, 58 : 1282 - 1286
  • [7] Candida esophagitis
    Nada Brnčić
    Brankica Mijandrušić-Sinčić
    Ivica Višković
    Wiener klinische Wochenschrift, 2005, 117 : 520 - 520
  • [8] Eosinophilic Esophagitis Mimicking Candida Esophagitis
    Yamazaki, Kenji
    Kojima, Kentaro
    Iwata, Hitoshi
    Kushima, Ryoji
    INTERNAL MEDICINE, 2019, 58 (06) : 887 - 887
  • [9] Prevalence and Risk Factors for Asymptomatic and HIV-negative Candida Esophagitis Patients among General Population in Taiwan
    Yang, Kuang Tsu
    Hsu, Ping I.
    Lin, Kung Hung
    Yu, Hsien Chung
    Chen, Wen Chi
    Chen, Yan Hua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 430 - 430
  • [10] Differential Diagnosis of Esophagitis: Eosinophilic Esophagitis, Candida, Cytomegalovirus
    Miehlke, Stephan
    VISZERALMEDIZIN, 2011, 27 (02): : 121 - 125